Showing results (341-350 of 384) with videos related to

Sort By:
Pageof 39
JAMA|April 8, 2020
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical TrialWilliam D Tap, Andrew J Wagner, Patrick Schöffski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2025
Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUEMichael C Heinrich, Jean-Yves Blay, Hans Gelderblom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 TrialPatrick Schöffski, Roberta Sanfilippo, Javier Martín-Broto, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapyKaran Kohli, Lu Yao, Theodore Scott Nowicki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2024
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 SuppressionSilvia Stacchiotti, Silvia Martini, Sandro Pasquali, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, et al.
Clinical and Translational Medicine|July 15, 2022
Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biologySamuel V Rasmussen, Jia Xiang Jin, Lissett R Bickford, et al.
JAMA Oncology|October 16, 2025
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus ReviewCésar Serrano, Sebastian Bauer, Jean-Yves Blay, et al.
BMJ Open|May 4, 2026
Pre-diagnostic route reported by patients with sarcoma from the Netherlands, the UK, Australia and New Zealand: early detection challenges for general practitioners - an international observational cohort studyEmily I Holthuis, Vicky L M N Soomers, Meena Rafiq, et al.
The Lancet. Oncology|October 9, 2020
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket studyMrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Pageof 39